The DOI matches its Crossref record.
Initiatives to Promote the Discovery of Drugs to Improve Cognitive Function in Severe Mental Illness
Abstract
This CME activity is expired. For more CME activities, visit CMEInstitute.com. Find more articles on this and other psychiatry and CNS topics: The Journal of Clinical Psychiatry The Primary Care Companion for CNS Disorders Article Abstract Current pharmacotherapy for treating schizophrenia islimited because treatments focus on positive symptom control rather thanimproving social and vocational function and few new treatments have beendeveloped in the past 50 years. To better facilitate the development oftreatments for the cognitive impairments in schizophrenia and for improvingfunctional outcome in schizophrenia, the Measurement and Treatment Research toImprove Cognition in Schizophrenia (MATRICS) program was established. TheMATRICS program has developed a way of measuring outcome in trials ofcognition-enhancing drugs, provided guidelines for doing studies ofcognition-enhancing drugs, and lookedat the most promising molecular targets for improving cognition using differentkinds of pharmacologic agents. By focusing on cognitive impairments and negativesymptoms, the functional outcomes of patients with schizophrenia may beimproved.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
A Meta-Analysis of Cognitive Remediation in Schizophrenia
McGurk, S. R., Twamley, E. W., Sitzer, D. I., McHugo, G. J., & Mueser, K. T. (2007) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.07060906 · Cited by 1,214
Prevalence of psychiatric disorders among older adults in long-term care homes: a systematic review
Seitz, D., Purandare, N., & Conn, D. (2010) · International Psychogeriatrics · doi:10.1017/s1041610210000608 · Cited by 592
Oxidative Stress, Chronic Disease, and Muscle Wasting
Moylan, J. S., & Reid, M. B. (2007) · Muscle & Nerve · doi:10.1002/mus.20743 · Cited by 416
Review of Medication Adherence in Children and Adults with ADHD
Adler, L. D., & Nierenberg, A. A. (2010) · Postgraduate Medicine · doi:10.3810/pgm.2010.01.2112 · Cited by 295
McGurk, S. R., Mueser, K. T., DeRosa, T. J., & Wolfe, R. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn182 · Cited by 272
Maura, J., & Weisman de Mamani, A. (2017) · Journal of Clinical Psychology in Medical Settings · doi:10.1007/s10880-017-9510-2 · Cited by 254
Kessing, L. V., Hansen, H. V., Hvenegaard, A., Christensen, E. M., Dam, H., Gluud, C., Wetterslev, J., & The Early Intervention Affective Disorders (EIA) Trial Group (2013) · British Journal of Psychiatry · doi:10.1192/bjp.bp.112.113548 · Cited by 219
Schizophrenia--Time to Commit to Policy Change
Fleischhacker, W. W., Arango, C., Arteel, P., Barnes, T. R. E., Carpenter, W., Duckworth, K., Galderisi, S., Halpern, L., Knapp, M., Marder, S. R., et al. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbu006 · Cited by 214
Self-citationBenson, S., Hahn, S., Tan, S., Mann, K., Janssen, O. E., Schedlowski, M., & Elsenbruch, S. (2009) · Human Reproduction · doi:10.1093/humrep/dep031 · Cited by 160
GWAS for executive function and processing speed suggests involvement of the CADM2 gene
Ibrahim-Verbaas, C. A., Bressler, J., Debette, S., Schuur, M., Smith, A. V., Bis, J. C., Davies, G., Trompet, S., Smith, J. A., Wolf, C., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.37 · Cited by 147
A review of the management of antidepressant discontinuation symptoms
Wilson, E., & Lader, M. (2015) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125315612334 · Cited by 103
Framer, A. (2021) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125321991274 · Cited by 73
A review of the adverse effects and safety of noradrenergic antidepressants
Whiskey, E., & Taylor, D. (2013) · Journal of Psychopharmacology · doi:10.1177/0269881113492027 · Cited by 64
Page, C. E., Epperson, C. N., Novick, A. M., Duffy, K. A., & Thompson, S. M. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02625-2 · Cited by 80
Groot, P. C., & van Os, J. (2020) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320932452 · Cited by 49
A review of autobiographical memory studies on patients with schizophrenia spectrum disorders
Zhang, Y., Kuhn, S. K., Jobson, L., & Haque, S. (2019) · BMC Psychiatry · doi:10.1186/s12888-019-2346-6 · Cited by 35
Relationship between olfactory function and social cognition in euthymic bipolar patients
Lahera, G., Ruiz-Murugarren, S., Fernández-Liria, A., Saiz-Ruiz, J., Buck, B. E., & Penn, D. L. (2016) · CNS Spectrums · doi:10.1017/s1092852913000382 · Cited by 34
Acheson, D. T., Twamley, E. W., & Young, J. W. (2013) · Frontiers in Neuroscience · doi:10.3389/fnins.2013.00103 · Cited by 26
The Patient Mania Questionnaire (PMQ-9): a Brief Scale for Assessing and Monitoring Manic Symptoms
Cerimele, J. M., Russo, J., Bauer, A. M., Hawrilenko, M., Pyne, J. M., Dalack, G. W., Kroenke, K., Unützer, J., & Fortney, J. C. (2022) · Journal of General Internal Medicine · doi:10.1007/s11606-021-06947-7 · Cited by 21
Metadata
- Authors
- Marder, S. R.
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2006-07-15
- Volume
- 67
- Issue
- 07
- Pages
- e03
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2023858503
- Cited by
- 218
- References
- 0
- FWCI
- 9.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.